Ozone modulates the effects of imipramine on immobility in the forced swim test, and nonspecific parameters of hippocampal oxidative stress in the rat.
Depression has been associated with oxidative stress. There is increased awareness of the role of environmental toxins in the development of mood disorders. Ozone, a pro-oxidant and environmental pollutant, has been noted to have central nervous system effects. We investigated the effects of acute and chronic ozone inhalation on the response of imipramine in the forced-swim test (FST) and on biomarkers of oxidative stress in rat hippocampus. Sprague Dawley rats were exposed to 0, 0.25 or 0.7 ppm ozone per inhalation 4 h daily for either 30 days (chronic) or once (acute). Animals were then injected intraperitoneally with imipramine (10 mg/kg) or saline 24, 5 and 1 h before the forced-swim test. Hippocampal superoxide accumulation and lipid peroxidation were measured. Imipramine evoked an antidepressant-like effect independent of acute or chronic ozone exposure. However, 0.7 ppm acute ozone and 0.25 ppm chronic ozone attenuated the antidepressant-like effects of imipramine. The ozone exposures also elevated hippocampal superoxide accumulation and lipid peroxidation. Importantly, imipramine reversed the lipid peroxidation induced by chronic ozone, thereby preventing cellular damage induced by oxidative stress. Ozone exposure presents a feasible model with etiological validity to investigate oxidative stress in depression and antidepressant action.
Mokoena
Mmalebuso L
ML
North-West University, Potchefstroom, 2520, South Africa.
Harvey
Brian H
BH
Oliver
Douglas W
DW
Brink
Christiaan B
CB
D000818:Animals; D000929:Antidepressive Agents, Tricyclic / Q000494:pharmacology / Q000627:therapeutic use; D003866:Depressive Disorder / Q000139:chemically induced* / Q000188:drug therapy*; D004195:Disease Models, Animal; D015386:Hazardous Substances / Q000037:antagonists & inhibitors / Q000633:toxicity; D006624:Hippocampus / Q000187:drug effects* / Q000378:metabolism; D007099:Imipramine / Q000494:pharmacology* / Q000627:therapeutic use; D007103:Immobilization; D008297:Male; D018384:Oxidative Stress / Q000187:drug effects* / Q000502:physiology; D010126:Ozone / Q000037:antagonists & inhibitors / Q000633:toxicity*; D005082:Physical Exertion / Q000187:drug effects* / Q000502:physiology; D051381:Rats; D017207:Rats, Sprague-Dawley; D013550:Swimming / Q000502:physiology; D016896:Treatment Outcome
D000929:Antidepressive Agents, Tricyclic; D015386:Hazardous Substances; D010126:Ozone; D007099:Imipramine
Neurosci Lett. 1996 Feb 2;204(1-2):49-52
8929975
Neurosci Lett. 1999 Jul 30;270(2):107-9
10462109
Metab Brain Dis. 2006 Sep;21(2-3):211-20
16865538
J Psychiatry Neurosci. 2000 Jan;25(1):43-7
10721683
Proc Natl Acad Sci U S A. 2003 Feb 4;100(3):1387-92
12552118
Eur Neuropsychopharmacol. 2008 Feb;18(2):128-40
17566715
Eur J Neurosci. 2001 Jul;14(1):161-6
11488960
Physiol Rev. 1998 Apr;78(2):547-81
9562038
Int J Neurosci. 2001;108(3-4):149-61
11699188
Eur J Biochem. 1993 Jul 15;215(2):213-9
7688300
Toxicol Pathol. 2002 Nov-Dec;30(6):620-50
12512863
Neurochem Res. 2008 Mar;33(3):508-17
17763945
J Affect Disord. 2001 Apr;64(1):43-51
11292519
Eur J Pharmacol. 1978 Feb 15;47(4):379-91
204499
Brain Res Dev Brain Res. 2001 Nov 26;131(1-2):149-52
11718845
Prog Neurobiol. 2005 Feb;75(3):207-46
15882775
Hippocampus. 2008;18(7):631-9
18306301
Physiol Behav. 2002 Dec;77(4-5):601-5
12527006
Prog Neuropsychopharmacol Biol Psychiatry. 2009 Mar 17;33(2):220-8
19059298
Neurochem Int. 2004 Dec;45(7):979-86
15337296
Curr Opin Pharmacol. 2007 Feb;7(1):18-21
17049922
Eur J Pharmacol. 2004 Aug 16;497(1):49-53
15321734
J Vis Exp. 2007;(7):269
18989440
J Neurochem. 1992 Nov;59(5):1609-23
1402908
Am J Psychiatry. 2003 Aug;160(8):1516-8
12900317
Redox Rep. 2008;13(2):87-100
18339251
Brain Res. 2003 Jan 3;959(1):128-34
12480166
Exp Physiol. 1997 Mar;82(2):291-5
9129943
Mutat Res. 2009 Mar 31;674(1-2):62-72
18977456
Anal Biochem. 1976 May 7;72:248-54
942051
Hum Psychopharmacol. 2008 Jul;23(5):371-84
18435513
Pflugers Arch. 1997 Apr;433(6):744-9
9049165
Int J Neuropsychopharmacol. 2009 May;12(4):553-9
18976544
Nat Rev Neurosci. 2009 Jun;10(6):434-45
19401723
Free Radic Biol Med. 2005 Feb 15;38(4):515-26
15649654
Int J Neuropsychopharmacol. 2010 May;13(4):461-73
19627650
Neurosci Lett. 1999 Oct 15;274(1):1-4
10530505
Eur J Pharmacol. 2007 Oct 15;572(1):23-31
17610875
Neuropsychopharmacology. 2008 Jan;33(1):88-109
17851537
Environ Res. 1998 Jan;76(1):33-9
9466895
Am J Psychiatry. 2004 Nov;161(11):1957-66
15514393
Am J Clin Nutr. 1991 Jan;53(1 Suppl):194S-200S
1985387
Biol Psychiatry. 2004 Aug 1;56(3):140-5
15271581
Arch Environ Health. 1975 Aug;30(8):373-8
1164043
Med Hypotheses. 2009 Mar;72(3):338-41
19027246
Environ Res. 2000 Jan;82(1):7-17
10677142
Neuropsychopharmacology. 2006 Jun;31(6):1165-76
16205774
Int J Neuropsychopharmacol. 2008 Sep;11(6):851-76
18205981
Free Radic Biol Med. 1991;11(1):41-6
1937128